"Benchmarking" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Method of measuring performance against established standards of best practice.
| Descriptor ID |
D019985
|
| MeSH Number(s) |
N04.452.500.150 N04.761.685.150 N04.761.700.150 N05.700.150 N05.715.360.650.150
|
| Concept/Terms |
Benchmarking- Benchmarking
- Best Practice Analysis
- Analysis, Best Practice
- Benchmark
- Benchmarks
|
Below are MeSH descriptors whose meaning is more general than "Benchmarking".
Below are MeSH descriptors whose meaning is more specific than "Benchmarking".
This graph shows the total number of publications written about "Benchmarking" by people in this website by year, and whether "Benchmarking" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 0 | 3 | 3 |
| 2007 | 0 | 1 | 1 |
| 2008 | 1 | 0 | 1 |
| 2009 | 0 | 1 | 1 |
| 2010 | 1 | 0 | 1 |
| 2011 | 0 | 1 | 1 |
| 2015 | 0 | 2 | 2 |
| 2016 | 0 | 1 | 1 |
| 2017 | 1 | 0 | 1 |
| 2019 | 1 | 1 | 2 |
| 2020 | 0 | 1 | 1 |
| 2021 | 0 | 2 | 2 |
| 2022 | 1 | 4 | 5 |
| 2023 | 1 | 2 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Benchmarking" by people in Profiles.
-
Quality metrics for single-photon emission computed tomography myocardial perfusion imaging: an ASNC information statement. J Nucl Cardiol. 2023 04; 30(2):864-907.
-
Early steps on the pathway to develop quality metrics that have an impact on postendoscopy upper gastrointestinal cancer rates. Gastrointest Endosc. 2022 09; 96(3):476-478.
-
Disagreement Between Hospital Rating Systems: Measuring the Correlation of Multiple Benchmarks and Developing a Quality Composite Rank. Am J Med Qual. 2020 May/Jun; 35(3):222-230.
-
Diffuse large B-cell lymphoma with primary treatment failure: Ultra-high risk features and benchmarking for experimental therapies. Am J Hematol. 2017 Feb; 92(2):161-170.
-
Probabilistic Measurement of Central Line-Associated Bloodstream Infections. Infect Control Hosp Epidemiol. 2016 Feb; 37(2):149-55.
-
A Consensus-Based Interpretation of the Benchmark Evidence from South American Trials: Treatment of Intracranial Pressure Trial. J Neurotrauma. 2015 Nov 15; 32(22):1722-4.
-
Comparison of investigator-delineated gross tumor volumes and quality assurance in pancreatic cancer: Analysis of the pretrial benchmark case for the SCALOP trial. Radiother Oncol. 2015 Dec; 117(3):432-7.
-
Defining world-class care in academic medicine: enablers and challenges. Adv Health Care Manag. 2015; 17:23-9.
-
AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation endorsed by the World Heart Federation and the Preventive Cardiovascular Nurses Association. J Am Coll Cardiol. 2011 Nov 29; 58(23):2432-46.
-
Quality assessment and improvement in interventional cardiology: a Position Statement of the Society of Cardiovascular Angiography and Interventions, Part II: public reporting and risk adjustment. Catheter Cardiovasc Interv. 2011 Oct 01; 78(4):493-502.